Results 211 to 220 of about 31,226 (229)

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine, 2006
Jeffrey S Heier
exaly  

Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine, 2010
James C Folk, Edwin M Stone
exaly  

Non-Neovascular Age-Related Macular Degeneration

2006
RAFAEL L. UFRET-VINCENTY, LEONID E. LERNER, PETER K. KAISER   +2 more
openaire   +1 more source

Introduction: Neovascular Age-Related Macular Degeneration

Ophthalmology, 2013
openaire   +1 more source

Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

Lancet, The
Paolo Lanzetta, Jean-François Korobelnik, Jeffrey S Heier   +2 more
exaly  

Neovascular (Exudative) Age-Related Macular Degeneration

2006
Neil M. Bressler, Susan B. Bressler, Stuart L. Fine   +2 more
openaire   +1 more source

Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial

Lancet, The
Timothy L Jackson, Riti Desai, Tunde Peto   +2 more
exaly  

Age-Related Macular Degeneration: Choroidal Neovascularization

2008
Neil M. Bressler, Susan B. Bressler, Evangelos S. Gragoudas   +2 more
openaire   +1 more source

Neovascular (Wet) Age-Related Macular Degeneration

2017
Colin S. Tan, SriniVas R. Sadda
openaire   +1 more source

VITREOMACULAR ADHESION AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Retina, 2012
openaire   +2 more sources